Precipitated withdrawal following codeine administration is dependent on CYP genotype.
暂无分享,去创建一个
A. Somogyi | F. Bochner | J. White | R. Irvine | M. Chew
[1] A. Somogyi,et al. The Relationship Between Mood State and Plasma Methadone Concentration in Maintenance Patients , 2001, Journal of clinical psychopharmacology.
[2] R. Tyndale,et al. Inhibition of cytochrome P450 2D6 modifies codeine abuse liability. , 2000, Journal of clinical psychopharmacology.
[3] R. Tyndale,et al. Cytochrome P450 2D6 and treatment of codeine dependence. , 2000, Journal of clinical psychopharmacology.
[4] R. Tyndale,et al. Mimicking Gene Defects to Treat Drug Dependence , 2000, Annals of the New York Academy of Sciences.
[5] B. Sproule,et al. Characteristics of dependent and nondependent regular users of codeine. , 1999, Journal of clinical psychopharmacology.
[6] A. Somogyi,et al. Steady‐state pharmacokinetics and pharmacodynamics in methadone maintenance patients: Comparison of those who do and do not experience withdrawal and concentration‐effect relationships , 1999, Clinical pharmacology and therapeutics.
[7] G. Tucker,et al. Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression. , 1999, Pharmacogenetics.
[8] R. Calvo,et al. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats. , 1999, The Journal of pharmacology and experimental therapeutics.
[9] F. Gonzalez,et al. Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2. , 1998, Pharmacogenetics.
[10] A. Malhotra,et al. Abuse of codeine-containing cough syrups: a report from India. , 1997, Addiction.
[11] A. Somogyi,et al. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6β-glucuronide in the rat , 1997, Pain.
[12] A. Somogyi,et al. CONCENTRATION‐EFFECT RELATIONSHIPS OF MORPHINE AND MORPHINE‐6β‐GLUCURONIDE IN THE RAT , 1997, Clinical and experimental pharmacology & physiology.
[13] U. Hofmann,et al. Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype , 1997, Clinical pharmacology and therapeutics.
[14] A. Somogyi,et al. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. , 1996, Drug metabolism reviews.
[15] S. Sindrup,et al. The pharmacogenetics of codeine hypoalgesia. , 1995, Pharmacogenetics.
[16] A. Somogyi,et al. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model. , 1994, The Journal of pharmacology and experimental therapeutics.
[17] M. Eichelbaum,et al. Thebaine O-demethylation to oripavine: genetic differences between two rat strains. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.
[18] M. Eichelbaum,et al. Codeine O-demethylation: rat strain differences and the effects of inhibitors. , 1991, Biochemical pharmacology.
[19] A. Somogyi,et al. Mu receptor binding of some commonly used opioids and their metabolites. , 1991, Life sciences.
[20] A. Somogyi,et al. Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia. , 1990, Life sciences.
[21] A. Somogyi,et al. Simultaneous determination of codeine, norcodeine and morphine in biological fluids by high-performance liquid chromatography with fluorescence detection. , 1989, Journal of chromatography.
[22] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[23] L. Ahtee,et al. Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice. , 1988, Arzneimittel-Forschung.
[24] C. Kozak,et al. Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. , 1987, DNA.
[25] W. Colburn,et al. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain , 1987, Clinical pharmacology and therapeutics.
[26] M. Rubenfield,et al. Sex and strain differences in hepatic debrisoquine 4-hydroxylase activity of the rat. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[27] F. Guengerich,et al. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. , 1984, Biochemistry.
[28] S. Yanaura,et al. Induction of physical dependence on codeine in the rat by drug-admixed food ingestion. , 1984, Japanese journal of pharmacology.
[29] J. Idle,et al. Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains , 1981, The Journal of pharmacy and pharmacology.
[30] S. Snyder,et al. Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.